Inventor · disambiguated record
Corey Anderson
Also filed as: ANDERSON COREY · ANDERSON COREY DON
55 granted patents·22 pending applications·662 citations·filing 2007–2024
99Inventor score
Top patents by PatentIndex Score
77 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0298US10787472B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·12 cites·40 claims
- 0398US10087143B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2017·Granted Oct 2, 2018·19 cites·51 claims
- 0498US9758483B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2016·Granted Sep 12, 2017·20 cites·35 claims
- 0598US9393235B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·24 cites·26 claims
- 0698US9051270B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Jun 9, 2015·36 cites·29 claims
- 0797US11591350B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Feb 28, 2023·7 cites·27 claims
- 0897US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 0997US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 1097US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 1197US10738009B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted Aug 11, 2020·10 cites·15 claims
- 1297US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 1397US9828397B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2016·Granted Nov 28, 2017·23 cites·109 claims
- 1497US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 1597US9783501B2Substituted quinolines as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·31 cites·23 claims
- 1696US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 1796US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 1896US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 1996US10253054B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2017·Granted Apr 9, 2019·17 cites·38 claims
- 2096US9464102B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Oct 11, 2016·23 cites·21 claims
- 2196US9421196B2Amides as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Aug 23, 2016·23 cites·18 claims
- 2296US9163042B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Oct 20, 2015·46 cites·20 claims
- 2395US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 2495US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 2595US10647661B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted May 12, 2020·15 cites·106 claims
- 2695US9108903B2Amides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Aug 18, 2015·33 cites·20 claims
- 2794US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 2894US11773119B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 3, 2023·2 cites·20 claims
- 2994US9139529B2Substituted quinoxalines as sodium channel modulatorsVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·26 cites·35 claims
- 3094US7846954B2Heterocyclic derivatives as modulators of ion channelsVERTEX PHARMA·Filed 2009·Granted Dec 7, 2010·27 cites·25 claims
- 3193US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 3293US12122788B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Oct 22, 2024·1 cites·21 claims
- 3393US11673864B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Jun 13, 2023·2 cites·17 claims
- 3493US11603351B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Mar 14, 2023·3 cites·27 claims
- 3592US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 3692US9511067B2Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Dec 6, 2016·17 cites·30 claims
- 3792US7842686B2CGRP receptor antagonistsVERTEX PHARMA·Filed 2009·Granted Nov 30, 2010·26 cites·23 claims
- 3891US12281057B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Apr 22, 2025·1 cites·15 claims
- 3991US11203571B2Sulfonamides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Dec 21, 2021·8 cites·26 claims
- 4088US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 4185US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 4281US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 4381US8598164B2Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2011·Granted Dec 3, 2013·5 cites·68 claims
- 4479US8163737B2CGRP receptor antagonistsANDERSON COREY·Filed 2007·Granted Apr 24, 2012·6 cites·12 claims
- 4578US8916565B2Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channelsHADIDA RUAH SARA SABINA·Filed 2012·Granted Dec 23, 2014·3 cites·35 claims
- 4678US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 4776US8343763B2Heterocyclic derivatives as modulators of ion channelsVERTEX PHARMA·Filed 2012·Granted Jan 1, 2013·2 cites·4 claims
- 4875US8163720B2Pyrrolidinyl phenyl sulphonamides as modulators of ion channelsMARTINBOROUGH ESTHER·Filed 2010·Granted Apr 24, 2012·2 cites·16 claims
- 4974US8129546B2Derivatives for modulation of ion channelsMARTINBOROUGH ESTHER·Filed 2010·Granted Mar 6, 2012·2 cites·54 claims
- 5071US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Corey Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →